Clinical Trial Update: LUMINIST: LUng Cancer Molecular Insights Non Interventional Study

View source ↗

Summary

AstraZeneca-sponsored non-interventional study in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: NSCLC | Status: COMPLETED